Pricing Log in Create free account

Incannex Healthcare Inc. (IXHL) vs TherapeuticsMD, Inc. (TXMD)

Incannex Healthcare Inc. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Incannex Healthcare Inc. is the larger, with a market value of $36.1M against $22.3M — 1.6× the size. Incannex Healthcare Inc. has the higher net margin (0.00% vs −6.64%) and the higher return on invested capital (0.00% vs −13.8%). Across the 16 metrics below, Incannex Healthcare Inc. leads on 8 and TherapeuticsMD, Inc. on 8.

Valuation

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 21.06 6.73 2.11
P/B 0.49 0.81 1.78
Price to free cash flow n/m 8.08 16.14
EV/EBITDA 1.36 n/m 12.58
EV/Sales (19.90) 85.06 2.73
Earnings yield (60.71%) (1.23%) (4.38%)
Free cash flow yield (39.17%) 12.37% 0.00%

Profitability

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Gross margin (0.10%) 100.00% 53.94%
Operating margin 0.00% (120.89%) 0.00%
Net margin 0.00% (6.64%) 0.00%
Free cash flow margin 0.00% 94.71% 0.00%
Return on equity (47.80%) (0.80%) (0.40%)
Return on assets (41.32%) (0.57%) (3.32%)
Return on invested capital 0.00% (13.77%) 0.00%

Growth

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 27.78% 10.01%
EPS growth (last fiscal year) 95.91% 73.68% 49.06%
Revenue growth, 5-year CAGR (29.64%) (45.84%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 48.81 3.22 2.31
Net debt to EBITDA 2.97 2.34 0.97

Dividend

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric IXHL TXMD Drug Manufacturers Specialty & Generic median
Market cap 36.12m 22.34m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack